Medical Condition News

RSS

Researchers develop nanoparticles delivering STING agonists for intravenous cancer immunotherapy

Cancer immunotherapy seeks to turn "cold" tumors into "hot" tumors––those that respond to immunotherapy––by awakening and enlisting the body's own immune system.

30 Sep 2021

Additional supportive care services benefit older adults receiving chemotherapy, study finds

A clinical trial led by researchers at City of Hope, a world-renowned cancer research and treatment organization, showed that patients over 65 receiving chemotherapy experienced significantly fewer treatment-related side effects when a multidisciplinary team of experts analyzed each case and introduced personalized interventions.

30 Sep 2021

Reading ability closely linked to altered retinal structure in geographic atrophy

In geographic atrophy, a late form of age-related macular degeneration (AMD), reading ability is closely related to the altered retinal structure.

30 Sep 2021

JDRF announces new grant to explore methods to alleviate diabetes distress

JDRF, the leading global nonprofit funder of type 1 diabetes (T1D) research, announces a new grant awarded to Albert Einstein College of Medicine and Montefiore Health System. Led by endocrinologist Shivani Agarwal, M.D., M.P.H., and by psychologist Jeffrey Gonzalez, Ph.D., the study will utilize telemedicine to deliver cognitive behavioral therapy to young adults with T1D to reduce diabetes-related distress.

30 Sep 2021

The connection between age and virulence of SARS-CoV-2 variants of concern

A new study focuses on determining the existence of an age-related heterogeneity in the severity of COVID-19.

30 Sep 2021

Key protein in the blood could help identify patients at risk of severe peripheral artery disease

To track cardiovascular health, doctors measure blood pressure, cholesterol levels and blood sugar, among a number of other cardiovascular disease risk factors.

30 Sep 2021

New collaboration launched to accelerate the development of treatments for rare cancers

The University of Texas MD Anderson Cancer Center and the Rare Cancer Research Foundation today announced the launch of a collaboration designed to accelerate the development of new treatments for rare cancers by empowering all patients in the United States to contribute tumor samples directly to MD Anderson for translational research efforts.

30 Sep 2021

Direct-to-consumer machine learning model incorrectly classifies rare, aggressive skin cancers

A new study has found that a direct-to-consumer machine learning model for detecting skin cancers incorrectly classified rare and aggressive cancers as low-risk.

30 Sep 2021

People living at higher altitudes have a lower risk of stroke and stroke-related death, finds study

Could living at high altitudes affect your chance of suffering a stroke? This intriguing question is at the heart of a new study in open-access journal Frontiers in Physiology.

30 Sep 2021

Aquaporin 5 induction may be a potential therapy to accelerate resurfacing of corneal defects

Corneal defects often heal themselves, but serious injuries that are left untreated can result in inflammation, infection, ulceration and even blindness.

30 Sep 2021

Research points to new opportunities to prevent treatment resistance in fragile X syndrome

Mark Bear, Picower Professor of Neuroscience at MIT, recalls the "eureka moment" 20 years ago when he realized that a severe developmental brain disorder - fragile X syndrome - might be treated with drugs that inhibit a neurotransmitter receptor called mGluR5.

29 Sep 2021

New 'priming' approach may improve the efficacy of chemotherapy for pancreatic cancer

A new approach to 'prime' the tumor environment may improve how effective chemotherapy is for pancreatic ductal adenocarcinoma, one of the most aggressive forms of pancreatic cancer.

29 Sep 2021

UTA researcher studying how TBI affects communication between neural cells

A University of Texas at Arlington researcher is studying how traumatic brain injuries (TBI) affect the ability of neural cells and surrounding cells to communicate with each other.

29 Sep 2021

Immunocompromised patients show decreased response to SARS-CoV-2 mRNA vaccines

Researchers explore the germinal cell responses in both healthy individuals and kidney transplant patients in their recent study.

29 Sep 2021

Study finds strong evidence of transplacental passage of IgG antibodies following COVID vaccination

In the current study, researchers investigate the transplacental transmission of antibodies in vaccinated pregnant women.

29 Sep 2021

Psychological treatment provides potent and durable relief for chronic back pain, study finds

Rethinking what causes pain and how great of a threat it is can provide chronic pain patients with lasting relief and alter brain networks associated with pain processing, according to new University of Colorado Boulder-led research.

29 Sep 2021

Study investigates the mechanism underlying kidney damage in COVID-19 patients

A review article published in the journal Frontiers in Physiology by researchers affiliated with the Federal University of São Paulo in Brazil discusses the mechanisms whereby SARS-CoV-2 damages the kidneys, potentially serving as a basis for further research in pursuit of treatments to prevent severe renal problems and even chronic kidney disease in COVID-19 patients.

29 Sep 2021

Clinical dilemmas in breast cancer patients solved by newly approved PET imaging agent

A non-invasive, patient-friendly imaging technique can help physicians make treatment decisions for breast cancer patients when diagnostic dilemmas arise.

29 Sep 2021

$94 million PCORI funding to support the next phase of PCORnet and new colorectal cancer study in older adults

The Patient-Centered Outcomes Research Institute Board of Governors today approved $61.3 million for a slate of several infrastructure projects that will support the activities of eight Clinical Research Networks to implement the next phase of PCORnet, the National Patient-Centered Clinical Research Network.

29 Sep 2021

Buck Institute receives $14 million NIH grant to focus on one of the major drivers of aging

Buck Institute professors Judith Campisi, PhD and Lisa Ellerby PhD, have been awarded a $14.3 million grant from the NIH's National Institute of Aging to study cellular senescence, one of the major hallmarks of aging, as a driver of Alzheimer's disease and other age-related dementias.

29 Sep 2021

Medical Condition News

Researchers develop nanoparticles delivering STING agonists for intravenous cancer immunotherapy

Additional supportive care services benefit older adults receiving chemotherapy, study finds

Reading ability closely linked to altered retinal structure in geographic atrophy

JDRF announces new grant to explore methods to alleviate diabetes distress

The connection between age and virulence of SARS-CoV-2 variants of concern

Key protein in the blood could help identify patients at risk of severe peripheral artery disease

New collaboration launched to accelerate the development of treatments for rare cancers

Direct-to-consumer machine learning model incorrectly classifies rare, aggressive skin cancers

People living at higher altitudes have a lower risk of stroke and stroke-related death, finds study

Aquaporin 5 induction may be a potential therapy to accelerate resurfacing of corneal defects

Research points to new opportunities to prevent treatment resistance in fragile X syndrome

New 'priming' approach may improve the efficacy of chemotherapy for pancreatic cancer

UTA researcher studying how TBI affects communication between neural cells

Immunocompromised patients show decreased response to SARS-CoV-2 mRNA vaccines

Study finds strong evidence of transplacental passage of IgG antibodies following COVID vaccination

Psychological treatment provides potent and durable relief for chronic back pain, study finds

Study investigates the mechanism underlying kidney damage in COVID-19 patients

Clinical dilemmas in breast cancer patients solved by newly approved PET imaging agent

$94 million PCORI funding to support the next phase of PCORnet and new colorectal cancer study in older adults

Buck Institute receives $14 million NIH grant to focus on one of the major drivers of aging

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News